The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 342:1666-1668 June 1, 2000 Number 22
NextNext

The Prospects for Red-Cell Substitutes

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Mullon, J.
-PubMed Citation
Blood is still the best thing possible to have in our veins, according to Woody Allen, and that is certainly the case when the blood is our own. We are not so confident, however, about other people's blood, the transfusion of which can cause unexpected, unexplained, and occasionally lethal complications. It is little wonder, then, that there are such high hopes for the development of safe alternatives to blood.

The term "blood substitute" is a misnomer. So-called blood substitutes replace just one or possibly two functions of transfused blood — oxygen delivery and volume expansion — and thus are more . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.